{"id":"https://openalex.org/W7225634935","doi":"https://doi.org/10.1007/s11095-026-04207-z","title":"Receptor-Targeted Sequential Phage Dosing against Pseudomonas aeruginosa PAO1: An In Vitro Proof-of-Concept Study","display_name":"Receptor-Targeted Sequential Phage Dosing against Pseudomonas aeruginosa PAO1: An In Vitro Proof-of-Concept Study","publication_year":2026,"publication_date":"2026-11-09","ids":{"openalex":"https://openalex.org/W7225634935","doi":"https://doi.org/10.1007/s11095-026-04207-z","pmid":"https://pubmed.ncbi.nlm.nih.gov/43004085"},"language":"en","primary_location":{"id":"doi:10.1007/s11095-026-04207-z","doi":"https://doi.org/10.1007/s11095-026-04207-z","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s11095-026-04207-z","pdf_url":"https://link.springer.com/content/pdf/10.1007/s11095-026-04207-z.pdf","source":{"id":"https://openalex.org/S103865650","display_name":"Pharmaceutical Research","issn_l":"0724-8741","issn":["0724-8741","1573-904X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmaceutical Research","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://link.springer.com/content/pdf/10.1007/s11095-026-04207-z.pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5161348339","display_name":"Mengyu Li","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I129604602","display_name":"The University of Sydney","ror":"https://ror.org/0384j8v12","country_code":"AU","type":"education","lineage":["https://openalex.org/I129604602"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Mengyu Li","raw_affiliation_strings":["Advanced Drug Delivery Group, Sydney Pharmacy School, Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, 2006, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Advanced Drug Delivery Group, Sydney Pharmacy School, Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, 2006, Australia","institution_ids":["https://openalex.org/I129604602"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5161320932","display_name":"Yue Cao","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I129604602","display_name":"The University of Sydney","ror":"https://ror.org/0384j8v12","country_code":"AU","type":"education","lineage":["https://openalex.org/I129604602"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Yue Cao","raw_affiliation_strings":["Advanced Drug Delivery Group, Sydney Pharmacy School, Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, 2006, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Advanced Drug Delivery Group, Sydney Pharmacy School, Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, 2006, Australia","institution_ids":["https://openalex.org/I129604602"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024110774","display_name":"Rachel Yoon Kyung Chang","orcid":"https://orcid.org/0000-0002-3251-5194","observed_orcids":["https://orcid.org/0000-0002-3251-5194"]},"institutions":[{"id":"https://openalex.org/I165143802","display_name":"The University of Queensland","ror":"https://ror.org/00rqy9422","country_code":"AU","type":"education","lineage":["https://openalex.org/I165143802"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Rachel Yoon Kyung Chang","raw_affiliation_strings":["Australian Institute of Bioengineering and Nanotechnology, The University of Queensland, Brisbane, QLD, 4072, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Australian Institute of Bioengineering and Nanotechnology, The University of Queensland, Brisbane, QLD, 4072, Australia","institution_ids":["https://openalex.org/I165143802"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005689093","display_name":"Dipesh Khanal","orcid":"https://orcid.org/0000-0001-6846-2373","observed_orcids":["https://orcid.org/0000-0001-6846-2373"]},"institutions":[{"id":"https://openalex.org/I129604602","display_name":"The University of Sydney","ror":"https://ror.org/0384j8v12","country_code":"AU","type":"education","lineage":["https://openalex.org/I129604602"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Dipesh Khanal","raw_affiliation_strings":["Advanced Drug Delivery Group, Sydney Pharmacy School, Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, 2006, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Advanced Drug Delivery Group, Sydney Pharmacy School, Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, 2006, Australia","institution_ids":["https://openalex.org/I129604602"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048069105","display_name":"Sandra Morales","orcid":"https://orcid.org/0000-0001-7085-2864","observed_orcids":["https://orcid.org/0000-0001-7085-2864"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sandra Morales","raw_affiliation_strings":["Phage Consulting, Sydney, New South Wales, 2100, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Phage Consulting, Sydney, New South Wales, 2100, Australia","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035215813","display_name":"Hee\u2010Won Bae","orcid":"https://orcid.org/0009-0002-7522-9208","observed_orcids":["https://orcid.org/0009-0002-7522-9208"]},"institutions":[{"id":"https://openalex.org/I4210148737","display_name":"CHA University","ror":"https://ror.org/04yka3j04","country_code":"KR","type":"education","lineage":["https://openalex.org/I4210148737","https://openalex.org/I4405258985"]}],"countries":["KR"],"is_corresponding":false,"raw_author_name":"Hee-Won Bae","raw_affiliation_strings":["Program of Biopharmaceutical Science, College of Pharmacy, CHA University, Gyeonggi-do, 13488, Korea"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Program of Biopharmaceutical Science, College of Pharmacy, CHA University, Gyeonggi-do, 13488, Korea","institution_ids":["https://openalex.org/I4210148737"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5157767223","display_name":"You-Hee Cho","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210148737","display_name":"CHA University","ror":"https://ror.org/04yka3j04","country_code":"KR","type":"education","lineage":["https://openalex.org/I4210148737","https://openalex.org/I4405258985"]}],"countries":["KR"],"is_corresponding":false,"raw_author_name":"You-Hee Cho","raw_affiliation_strings":["Program of Biopharmaceutical Science, College of Pharmacy, CHA University, Gyeonggi-do, 13488, Korea"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Program of Biopharmaceutical Science, College of Pharmacy, CHA University, Gyeonggi-do, 13488, Korea","institution_ids":["https://openalex.org/I4210148737"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5112662619","display_name":"Chan Hak-Kim","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I129604602","display_name":"The University of Sydney","ror":"https://ror.org/0384j8v12","country_code":"AU","type":"education","lineage":["https://openalex.org/I129604602"]}],"countries":["AU"],"is_corresponding":true,"raw_author_name":"Hak-Kim Chan","raw_affiliation_strings":["Advanced Drug Delivery Group, Sydney Pharmacy School, Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, 2006, Australia. kim.chan@sydney.edu.au"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Advanced Drug Delivery Group, Sydney Pharmacy School, Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, 2006, Australia. kim.chan@sydney.edu.au","institution_ids":["https://openalex.org/I129604602"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5112662619"],"corresponding_institution_ids":["https://openalex.org/I129604602"],"apc_list":{"value":4690,"currency":"USD","value_usd":4690},"apc_paid":{"value":4690,"currency":"USD","value_usd":4690},"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11048","display_name":"Bacteriophages and microbial interactions","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2406","display_name":"Virology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11048","display_name":"Bacteriophages and microbial interactions","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2406","display_name":"Virology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11826","display_name":"Ocular Infections and Treatments","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10593","display_name":"Bacterial biofilms and quorum sensing","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/phage-therapy","display_name":"phage therapy","score":0.9120000004768372},{"id":"https://openalex.org/keywords/pseudomonas-aeruginosa-pao1","display_name":"Pseudomonas aeruginosa PAO1","score":0.9350000023841858},{"id":"https://openalex.org/keywords/lipopolysaccharide","display_name":"lipopolysaccharide","score":0.8610000014305115},{"id":"https://openalex.org/keywords/type-iv-pili","display_name":"type IV pili","score":0.9929999709129333},{"id":"https://openalex.org/keywords/phage-resistance","display_name":"phage resistance","score":0.718999981880188},{"id":"https://openalex.org/keywords/fitness-cost","display_name":"fitness cost","score":0.6399999856948853},{"id":"https://openalex.org/keywords/time-kill-kinetics","display_name":"time-kill kinetics","score":0.6779999732971191},{"id":"https://openalex.org/keywords/phage-resistant-mutants","display_name":"phage-resistant mutants","score":0.628000020980835}],"concepts":[{"id":"https://openalex.org/C2777288759","wikidata":"https://www.wikidata.org/wiki/Q4164182","display_name":"Dosing","level":2,"score":0.7754999995231628},{"id":"https://openalex.org/C2777637488","wikidata":"https://www.wikidata.org/wiki/Q31856","display_name":"Pseudomonas aeruginosa","level":3,"score":0.718500018119812},{"id":"https://openalex.org/C89423630","wikidata":"https://www.wikidata.org/wiki/Q7193","display_name":"Microbiology","level":1,"score":0.5769000053405762},{"id":"https://openalex.org/C2776441376","wikidata":"https://www.wikidata.org/wiki/Q165028","display_name":"Bacteriophage","level":4,"score":0.511900007724762},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.45910000801086426},{"id":"https://openalex.org/C94665300","wikidata":"https://www.wikidata.org/wiki/Q63391344","display_name":"Antibiotic resistance","level":3,"score":0.4523000121116638},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.45159998536109924},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.4307999908924103},{"id":"https://openalex.org/C501593827","wikidata":"https://www.wikidata.org/wiki/Q12187","display_name":"Antibiotics","level":2,"score":0.40619999170303345},{"id":"https://openalex.org/C523546767","wikidata":"https://www.wikidata.org/wiki/Q10876","display_name":"Bacteria","level":2,"score":0.37450000643730164},{"id":"https://openalex.org/C3019249092","wikidata":"https://www.wikidata.org/wiki/Q274493","display_name":"Antibacterial agent","level":3,"score":0.36489999294281006},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.34119999408721924},{"id":"https://openalex.org/C114851261","wikidata":"https://www.wikidata.org/wiki/Q12147416","display_name":"Drug resistance","level":2,"score":0.337799996137619},{"id":"https://openalex.org/C182707283","wikidata":"https://www.wikidata.org/wiki/Q7315622","display_name":"Resistance mutation","level":5,"score":0.2800999879837036},{"id":"https://openalex.org/C2994294914","wikidata":"https://www.wikidata.org/wiki/Q1645075","display_name":"Acquired resistance","level":3,"score":0.274399995803833},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.2660999894142151},{"id":"https://openalex.org/C547475151","wikidata":"https://www.wikidata.org/wiki/Q25419","display_name":"Escherichia coli","level":3,"score":0.2639000117778778},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.26269999146461487},{"id":"https://openalex.org/C2910978944","wikidata":"https://www.wikidata.org/wiki/Q165028","display_name":"Bacterial virus","level":5,"score":0.2581999897956848},{"id":"https://openalex.org/C203233990","wikidata":"https://www.wikidata.org/wiki/Q1511135","display_name":"Multiplicity of infection","level":3,"score":0.25060001015663147}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1007/s11095-026-04207-z","doi":"https://doi.org/10.1007/s11095-026-04207-z","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s11095-026-04207-z","pdf_url":"https://link.springer.com/content/pdf/10.1007/s11095-026-04207-z.pdf","source":{"id":"https://openalex.org/S103865650","display_name":"Pharmaceutical Research","issn_l":"0724-8741","issn":["0724-8741","1573-904X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmaceutical Research","raw_type":"journal-article"},{"id":"pmid:43004085","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/43004085","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmaceutical research","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1007/s11095-026-04207-z","doi":"https://doi.org/10.1007/s11095-026-04207-z","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s11095-026-04207-z","pdf_url":"https://link.springer.com/content/pdf/10.1007/s11095-026-04207-z.pdf","source":{"id":"https://openalex.org/S103865650","display_name":"Pharmaceutical Research","issn_l":"0724-8741","issn":["0724-8741","1573-904X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmaceutical Research","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.8048999905586243,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320315885","display_name":"Australian Government","ror":"https://ror.org/0314h5y94"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7225634935.pdf","grobid_xml":"https://content.openalex.org/works/W7225634935.grobid-xml"},"referenced_works_count":35,"referenced_works":["https://openalex.org/W200599908","https://openalex.org/W1507359686","https://openalex.org/W1557639571","https://openalex.org/W1989381870","https://openalex.org/W2006277776","https://openalex.org/W2019197162","https://openalex.org/W2026422709","https://openalex.org/W2050998488","https://openalex.org/W2109038233","https://openalex.org/W2116153891","https://openalex.org/W2150167739","https://openalex.org/W2151024250","https://openalex.org/W2339070543","https://openalex.org/W2399110743","https://openalex.org/W2472783748","https://openalex.org/W2514820310","https://openalex.org/W2555970702","https://openalex.org/W2794657941","https://openalex.org/W2806659441","https://openalex.org/W2811180668","https://openalex.org/W2903381708","https://openalex.org/W2915792392","https://openalex.org/W2975499037","https://openalex.org/W2991116396","https://openalex.org/W3009286821","https://openalex.org/W3127141630","https://openalex.org/W3202808319","https://openalex.org/W4205772264","https://openalex.org/W4210964139","https://openalex.org/W4296708721","https://openalex.org/W4400087023","https://openalex.org/W4403098193","https://openalex.org/W4404062327","https://openalex.org/W4406430039","https://openalex.org/W4409952476"],"related_works":["https://openalex.org/W2150167739","https://openalex.org/W3186874933","https://openalex.org/W4380265077","https://openalex.org/W7140282410","https://openalex.org/W7207747082","https://openalex.org/W7118649057","https://openalex.org/W4414752238","https://openalex.org/W4366817130","https://openalex.org/W2975499037","https://openalex.org/W7125155878"],"abstract_inverted_index":{"PURPOSE:":[0],"Antibiotic":[1],"resistance":[2,103],"has":[3],"intensified":[4],"the":[5,15,82,115,191],"need":[6],"for":[7,25],"alternative":[8],"therapies,":[9],"such":[10],"as":[11],"bacteriophage":[12],"administration.":[13],"However,":[14],"optimal":[16],"delivery":[17],"strategy-specifically":[18],"simultaneous":[19,71,126,203],"versus":[20],"sequential":[21,37,73,140,195],"dosing-remains":[22],"poorly":[23],"defined":[24],"ensuring":[26],"sustainable":[27],"efficacy.":[28],"This":[29,205],"single-strain,":[30],"in":[31,105,178],"vitro":[32],"proof-of-concept":[33,206],"study":[34],"evaluated":[35],"receptor-targeted":[36],"dosing":[38,74,196,213],"using":[39],"phages":[40],"Dobby,":[41],"targeting":[42,46],"lipopolysaccharide,":[43],"and":[44,67,72,101,186,219],"MPK7,":[45,121],"type":[47],"IV":[48],"pili,":[49],"against":[50],"P.":[51,216],"aeruginosa":[52,217],"PAO1.":[53],"METHODS:":[54],"Time-kill":[55],"assays":[56],"were":[57],"conducted":[58],"at":[59],"various":[60],"multiplicities":[61],"of":[62,85,210],"infection":[63],"(MOI:":[64],"0.01,":[65],"1,":[66],"100)":[68],"to":[69,80,97,169,183],"compare":[70],"regimens.":[75],"Resistance":[76,155],"profiling":[77,156],"was":[78,95,122],"performed":[79],"assess":[81],"fitness":[83,163],"costs":[84],"resulting":[86],"isolates,":[87],"while":[88],"atomic":[89],"force":[90],"microscopy":[91],"infrared":[92],"spectroscopy":[93],"(AFM-IR)":[94],"utilized":[96],"identify":[98],"chemical":[99,176],"signatures":[100],"underlying":[102],"mechanisms":[104],"phage-resistant":[106],"mutants.":[107],"RESULTS:":[108],"Sequential":[109],"treatment,":[110],"particularly":[111],"initiating":[112],"therapy":[113],"with":[114],"LPS-specific":[116],"phage":[117,212,220],"Dobby":[118],"followed":[119],"by":[120],"more":[123,167,198],"effective":[124],"than":[125,202],"dosing,":[127],"achieving":[128],"bacterial":[129,153,200],"reductions":[130],"exceeding":[131],"3-log10":[132],"within":[133],"48":[134],"h.":[135],"Notably,":[136],"low":[137],"MOI":[138,148],"(0.01)":[139],"treatments":[141,150],"maintained":[142],"sustained":[143,199],"population":[144],"suppression,":[145],"whereas":[146],"high":[147],"(100)":[149],"triggered":[151],"rapid":[152],"rebound.":[154],"confirmed":[157],"that":[158],"Dobby-resistant":[159],"isolates":[160],"exhibited":[161],"lower":[162],"costs,":[164],"rendering":[165],"them":[166],"susceptible":[168],"subsequent":[170],"MPK7":[171],"treatment.":[172,204],"AFM-IR":[173],"revealed":[174],"unique":[175],"alterations":[177],"resistant":[179],"mutants,":[180],"specifically":[181],"linked":[182],"LPS":[184],"truncation":[185],"TFP":[187],"dysfunction.":[188],"CONCLUSIONS:":[189],"In":[190],"Dobby-MPK7-PAO1":[192],"model,":[193],"receptor-specific":[194],"produced":[197],"suppression":[201],"supports":[207],"further":[208],"evaluation":[209],"temporal":[211],"across":[214],"diverse":[215],"strains":[218],"combinations.":[221]},"counts_by_year":[],"updated_date":"2026-11-11T12:16:26.678958","created_date":"2026-11-10T00:00:00"}